Loyal, a company developing treatments for longevity in dogs, recently announced that they have "completed the technical effectiveness portion of their conditional approval for [their first drug candidate]".
Will they successfully establish efficacy (according to the FDA)? Resolves NO if they fail for any reason, including, for example, running out of money before they complete their studies.
Get Ṁ600 play money
Related questions
Sort by:
reposted
Loyal is in my broader professional orbit (eg Celine was at the Future Forum), so I was surprised to see a LessWrong post arguing that their drug doesn't work...
reposted
Comment hidden
Related questions
Will the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial?
58% chance
Will AOH1996 succeed in Phase I trial?
81% chance
Will the Robust Mouse Rejuvenation Study by the LEVF succeed in increasing mouse lifespan 12 months?
42% chance
Will the pre-clinical results on the cancer drug AOH1996 be broadly confirmed by independent team(s)?
26% chance
Will LOY-001 establish safety?
80% chance
Will the scientific consensus in 2030 be that Lantern Bioworks' product is effective at reducing cavities?
50% chance
What will the phase 3 clinical trial results report for vaccine efficacy (%) of the R21 malaria vaccine at 48 months?
Will the Phase 2 Trials of Lepodisiran be a Success?
56% chance
Will an independent RCT study evaluating Silexan for anxiety find a standardized effect size greater than 0.5?
25% chance
What will the phase 3 clinical trial results report for vaccine efficacy (%) of the R21 malaria vaccine at 24 months?